Q4 2016 Holdings
Filed 2017-02-14 | 23 holdings | $106.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $52.2M | 2,666,354 | 49.1% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $29.8M | 491,608 | 28.1% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $16.9M | 510,666 | 15.9% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $6.5M | 1,273,933 | 6.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $121.3K | 2,730,887 | 0.1% |
| Horizon Pharma PLC | SHS | G4617B105 | $93.7K | 5,793,903 | 0.1% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $83.3K | 580,701 | 0.1% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $77.2K | 25,052,380 | 0.1% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $57.5K | 1,153,944 | 0.1% |
| Retrophin Inc | COM | 761299106 | $52.5K | 2,772,156 | 0.0% |
| Globus MED Inc(GMED) | CL A | 379577208 | $46.2K | 1,860,000 | 0.0% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $44.2K | 3,553,943 | 0.0% |
| Mednax Inc(MD) | COM | 58502B106 | $44.0K | 660,000 | 0.0% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $38.8K | 2,328,932 | 0.0% |
| Merrimack Pharmaceuticals in | COM | 590328100 | $37.0K | 9,067,998 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG) | COM | 00163U106 | $35.7K | 1,026,902 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $23.9K | 2,723,471 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $20.4K | 631,805 | 0.0% |
| Novadaq Technologies Inc | COM | 66987G102 | $17.1K | 2,413,179 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $8.9K | 2,982,940 | 0.0% |
| Biolase Inc | COM | 090911108 | $2.0K | 1,449,022 | 0.0% |
| Seaspine Hldgs Corp(SPNEUSD) | COM | 81255T108 | $1.0K | 128,127 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $362 | 46,752 | 0.0% |